The ErbB receptors and their role in cancer progression.

By Thomas Holbro, G. Civenni, N. Hynes. Experimental Cell Research, 2003

668 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. (2003, neutral): “However, receptor display, signaling responses (Holbro et al., 2003; Yarden and Sliwkowski, 2001).”
ErbB receptors: directing key signaling networks throughout life. (2004, background): “Through these transcriptional programs, the ErbB signaling network controls a wide palette of biological outcomes, including cell proliferation, differentiation, survival, adhesion, and migration (53).”
Insight into nanoparticle cellular uptake and intracellular targeting (2014, positive): “The epidermal growth factor receptor (EGFR, also known as HER1) is a member of the ErbB tyrosine kinase family including HER2 (ErbB2), HER3 (ErbB3), and HER4 (ErbB4) [114,115].”
Regulation of Raf-1 by direct feedback phosphorylation. (2005, background): “…or amplification of upstream3 Department of Medicine regulators of Raf-1, such as receptor tyrosine kinasesBeth Israel Deaconess Medical Center (Holbro et al., 2003; Marmor et al., 2004) and Ras (Bos,Harvard Medical School 1989; Pruitt and Der, 2001), frequently induces deregu-Boston,…”
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. (2004, neutral): “, 2003; Schlessinger, (Burgess et al., 2003; Holbro et al., 2003; Yarden and Sliwkow- 2000).”